6014-06-8 Usage
Purpose
Medication used to treat gout, kidney stones, and decrease uric acid levels in cancer patients
Mechanism of Action
Inhibits the production of uric acid by blocking the enzyme xanthine oxidase
Availability
Tablet and injectable forms
Side Effects
Rash, nausea, and liver problems (in some cases)
Benefits
Prevents formation of uric acid crystals, reduces inflammation and pain in joints, and supports cancer treatment by managing uric acid levels
Check Digit Verification of cas no
The CAS Registry Mumber 6014-06-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,0,1 and 4 respectively; the second part has 2 digits, 0 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 6014-06:
(6*6)+(5*0)+(4*1)+(3*4)+(2*0)+(1*6)=58
58 % 10 = 8
So 6014-06-8 is a valid CAS Registry Number.
6014-06-8Relevant academic research and scientific papers
Electrophilic cyanations. I. Synthesis of thiocyanato-heteroarenes and tosylheteroarenes from mercapto-heteroarenes using p-toluenesulfonyl cyanide
Miyashita, Akira,Nagasaki, Izuru,Kawano, Akiko,Suzuki, Yumiko,Iwamoto, Ken-Ichi,Higashino, Takeo
, p. 745 - 755 (2007/10/03)
Mercaptoheteroarenes (1) underwent electrophilic cyanation with p-toluenesulfonyl cyanide (TsCN) in THF in the presence of NaH to give the corresponding thiocyanatoheteroarenes (2) in moderate to good yields. In DMF, tosylheteroarenes (4) were formed by substitution with p-toluenesulfinate ion through thiocyanatoheteroarenes (2).